StandardAero, Inc.
SARO
$28.49
-1.66%
StandardAero, Inc. is one of the largest independent providers of maintenance, repair, and overhaul (MRO) services for aircraft engines, supporting leading engine platforms across the commercial, military, and business jet end markets through OEM licenses, organized into engine services and component repair segments with a global facility network concentrated in North America and Europe. The company occupies a distinct position as a pure-play, independent aftermarket services partner — a structurally recurring-revenue business model underpinned by long-term OEM relationships and the mandatory nature of engine maintenance, rather than a capital-intensive OEM manufacturer. The current investor narrative centers on the company's post-IPO execution (listed October 2024), with the most recent Q3 2026 print showing revenue growth of roughly 4% year-over-year, margin expansion, and a sharp post-earnings stock rally of over 9% on November 6, 2026, alongside an active capital return program via buybacks and debt repayment. Debate now hinges on whether the aftermarket MRO cycle can sustain mid-single-digit growth and whether margin gains from the commercial aerospace segment are durable enough to justify the stock's premium multiple, particularly given the recent 40% peak-to-trough drawdown that has left shares well below their 52-week high.…
SARO
StandardAero, Inc.
$28.49
Related headlines
Investment Opinion: Should I buy SARO Today?
Rating: Buy (moderate conviction). The thesis is that StandardAero is a structurally recurring-revenue MRO franchise whose valuation has reset to post-IPO lows — PS of 1.55x and EV/Sales of 1.79x versus 8.80x in Q3 2024 — while Q3 2026 delivered 38% EPS growth ($0.29 vs. $0.21) on margin expansion, and 11 of 14 analysts rate it Buy with a $33.96 average target implying +22.9% upside from $27.63. The core reasoning is that the market is pricing a sub-4% growth stall into a business whose forward PE of 15.5x already embeds the earnings step-up to $2.535, leaving asymmetric re-rating potential if commercial aerospace aftermarket volumes hold.
Supporting evidence: (1) valuation — forward PE of 15.5x versus trailing 34.1x and a historical 25x–38x band, with PS at 1.55x near the bottom of its post-IPO range; (2) growth — Q3 revenue of $1.558 billion grew 3.97% YoY, decelerated but positive, against a consensus forward revenue average of $8.84 billion; (3) profitability — gross margin expanded to 16.82% from 14.90% a year ago and 13.22% in Q1 2026, lifting operating margin to 10.34% from 9.13%; (4) cash and balance sheet — TTM free cash flow of $321.3 million (3.4% FCF yield), current ratio of 2.20, $144.2 million of Q3 debt repayment and $50.0 million of buybacks; (5) analyst support — zero sell ratings, recommendation mean of 1.67, and a $42.40 high target (+53%).
Risks and conditions: the three biggest threats are (a) revenue growth slipping below 3% and breaking the forward EPS bridge, (b) margin reversal from the 16.82% Q3 gross margin level given thin structural margins and $40.5 million of quarterly interest expense, and (c) working-capital-driven FCF volatility (Q1 2026 was -$135.1 million on a $249.0 million drain). This Buy would upgrade to a high-conviction stance if Q4 revenue growth reaccelerates above 5% with gross margin holding above 16.5%, and would downgrade to Hold if growth falls below 3% or the forward EPS estimate is cut toward the $2.399 low. Verdict: undervalued relative to its own post-IPO history and reasonably valued on forward earnings, though not cheap on trailing metrics — a data-driven assessment, not personalized advice.
Sign up to view all
SARO 12-Month Price Forecast
The setup is a valuation-reset story with demonstrated operating leverage: shares at $27.63 sit ~20% below the $34.48 52-week high after a 40.34% max drawdown, yet Q3 delivered 38% EPS growth on margin expansion and the stock rallied 9.21% on November 6. The forward PE of 15.5x versus the historical 25x–38x band means the market is discounting a growth stall that has not fully materialized, and the 11/4/0 Buy/Hold/Sell consensus with zero sell ratings supports the view that the selloff was overdone. The offsetting tension is the 3.97% revenue growth and lumpy free cash flow (Q1 2026 at -$135.1 million), which make the $2.535 forward EPS the single load-bearing assumption. I would upgrade to high confidence if Q4 shows revenue growth above 5% with gross margin above 16.5%, and downgrade to neutral if growth falls below 3% or the forward EPS estimate is cut toward $2.399.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on StandardAero, Inc.'s 12-month outlook, with a consensus price target around $34.17 and implied upside of +19.9% versus the current price.
Average Target
$34.17
14 analysts
Implied Upside
+19.9%
vs. current price
Analyst Count
14
covering this stock
Price Range
$27 - $42
Analyst target range
Coverage is robust for a recent IPO, with 14 analysts and a Buy/Hold/Sell distribution of 11/4/0, yielding a consensus recommendation of "buy" and a recommendation mean of 1.67 (where 1.0 is a strong buy). The average target price of $33.96 implies roughly +22.9% upside from the current $27.63, a meaningfully bullish signal that stands in contrast to the stock's -6.78% YTD performance and suggests analysts view the recent selloff as overdone. The consensus leans clearly bullish, with no sell ratings and a 79% buy ratio, and the estimated forward EPS average of $2.535 and revenue average of $8.84 billion underpin the constructive stance.
The target range of $25.00 to $42.40 is wide — a 70% spread from low to high — signaling meaningful dispersion in conviction and outcome scenarios. The high target of $42.40 (roughly +53% upside) likely assumes multiple expansion back toward historical levels combined with the forward EPS materializing and margin expansion continuing in Commercial Aerospace; the low target of $25.00 (about -9.5% downside) appears to price in growth stalling near current sub-4% levels with margin compression and no re-rating. Institutional ratings show a mild negative drift — Jefferies downgraded from Buy to Hold on June 2, 2026, while UBS upgraded from Neutral to Buy on May 11, 2026 — but the most recent actions (RBC Outperform on October 28, CIBC Outperform on October 26, Susquehanna Positive on October 1) confirm that sell-side sentiment has stabilized and turned constructive into the Q3 print. The wide spread and the clustering of recent reiterations at Outperform/Positive suggest analysts are holding their bullish theses pending confirmation that the Q3 margin expansion and post-earnings rally mark a durable inflection rather than a one-quarter bounce.
Bulls vs Bears: SARO Investment Factors
The bear case currently has stronger near-term evidence: revenue growth has decelerated to 3.97% and sequentially declined for two straight quarters, the stock is down 6.78% YTD with a 40.34% max drawdown, and the entire forward valuation depends on an EPS step-up from a $0.0294 trailing base to $2.535. However, the bull case is gaining momentum — Q3 delivered 38% EPS growth on margin expansion (gross margin up to 16.82% from 14.90%), the stock rallied 9.21% on November 6, and 11 of 14 analysts rate it Buy with a $33.96 average target implying +22.9% upside. The single most important tension is whether the Q3 margin expansion and post-earnings rally mark a durable inflection or a one-quarter bounce: if commercial aerospace aftermarket volumes reaccelerate above mid-single digits, the 15.5x forward PE re-rates toward its historical 25x–38x range; if growth stalls below 4%, the multiple may not recover. On balance, the evidence is finely balanced but tilts modestly bullish given the valuation reset, analyst conviction, and demonstrated operating leverage.
Bullish
- Forward PE of 15.5x implies deep value: Trailing PE of 34.1x collapses to a forward PE of 15.5x on consensus EPS of $2.535, meaning the market is pricing in a dramatic earnings step-up. If that estimate materializes, shares trade at a reasonable multiple for a recurring-revenue aftermarket business, and the 11/4/0 Buy/Hold/Sell consensus with a $33.96 average target (+22.9% upside) suggests analysts believe the forward number is credible.
- Margin expansion driving 38% EPS growth: Q3 2026 EPS of $0.29 versus $0.21 a year ago represents roughly 38% earnings growth on just 3.97% revenue growth. Gross margin expanded to 16.82% from 14.90% in Q3 2025 and 13.22% in Q1 2026, while operating margin rose to 10.34% from 9.13% in Q1, demonstrating genuine operating leverage as cost of revenue growth moderates.
- Analyst sentiment stabilized and constructive: Recent actions cluster at Outperform/Positive — RBC on October 28, CIBC on October 26, Susquehanna on October 1 — with zero sell ratings across 14 analysts and a recommendation mean of 1.67. The $42.40 high target implies +53% upside, and the absence of any sell rating despite a 40.34% max drawdown signals the sell-side views the selloff as overdone.
- Valuation reset to post-IPO lows: PS ratio has collapsed from 8.80x in Q3 2024 and 6.80x in Q2 2025 to just 1.55x today, with EV/Sales at 1.79x — inexpensive in absolute terms for an aerospace aftermarket services business. The stock trades near the bottom of its own post-IPO valuation band on every sales-based measure, leaving substantial re-rating potential if growth reaccelerates.
Bearish
- Revenue growth decelerated to 3.97%: Q3 2026 revenue of $1.558 billion grew only 3.97% year-over-year, and sequentially declined from $1.600 billion in Q2 and $1.627 billion in Q1. This sub-4% pace is the central fundamental problem and explains why the stock de-rated through 2026 despite positive earnings momentum — the forward EPS of $2.535 requires a reacceleration that has not yet appeared.
- Trailing PE of 34.1x embeds execution risk: The gap between trailing PE of 34.1x and forward PE of 15.5x means the market has already priced in forward earnings more than doubling. If consensus EPS of $2.535 is missed — the low estimate is $2.39891 — the stock would re-rate sharply higher on a trailing basis, and the PCF ratio of 29.7x against a 1.55x sales multiple highlights how much of the valuation depends on working-capital-driven cash flow normalizing.
- 40.34% max drawdown shows fragility: The stock suffered a 40.34% peak-to-trough decline and remains 6.78% lower YTD versus the S&P 500's 7.83% gain, a -14.61 percentage point relative strength gap. At $27.63 it sits only at ~54% of its 52-week range ($19.56–$34.48), and the 6.82 short ratio indicates meaningful bearish positioning that could amplify volatility on any disappointment.
- Working capital drives volatile cash flow: Quarterly free cash flow swung from -$135.1 million in Q1 2026 (a $249.0 million working capital drain) to +$51.3 million in Q2 and +$98.2 million in Q3. This lumpiness, inherent to MRO receivables and inventory cycles, makes the 3.4% FCF yield less reliable than it appears and constrains the durability of the buyback and deleveraging program.
SARO Technical Analysis
SARO is in a recovery phase following a pronounced downtrend, with the stock up just 2.94% over the trailing year but still 6.78% lower year-to-date, a clear underperformance versus the S&P 500's 7.83% YTD gain. At the current price of $27.63, the stock sits at approximately 54% of its 52-week range (low of $19.56 to high of $34.48), meaning it has recovered roughly halfway from its lows but remains about 20% below its high — a positioning that reflects repair rather than full momentum, and one that leaves room for either continuation or a failed retest. The 40.34% max drawdown underscores how violent the prior decline was, and the fact that price is now well off the October low of $19.76 signals buyers have stepped in decisively at the lower end of the range.
Short-term momentum is exceptionally strong and sharply divergent from the longer-term trend: the stock is up 36.44% over the past month versus a 4.99% decline in SPY, producing a relative strength of +41.43 percentage points, while the 3-month change remains -5.34% and the 6-month change is +9.90%. This divergence — a powerful one-month surge against a still-negative three-month and YTD backdrop — is characteristic of a mean-reversion rally off oversold conditions, likely catalyzed by the November 6 earnings release (the stock jumped 9.21% on that single session on elevated volume of roughly 6.85 million shares). The acceleration from the October 14 low of $19.76 to $27.63 in under a month (+39.8%) is steep enough that near-term overbought conditions are probable, and traders should watch for consolidation or a pullback toward the $23–25 breakout zone before the next leg higher.
Key technical levels are well defined: support sits at the 52-week low of $19.56, with a secondary shelf around $21–22 where the stock based in late October, while resistance is the 52-week high of $34.48, with intermediate resistance near $30–31 (the August 2026 highs). A decisive breakout above $31 on volume would confirm a trend reversal and open a path back toward the highs, whereas a breakdown below $21 would signal the rally was a dead-cat bounce and re-expose the $19.56 low. With a beta of 0.821, SARO is roughly 18% less volatile than the broader market, which is unusual for a recent IPO and suggests the stock's sharp moves are more idiosyncratic (earnings-driven) than market-beta-driven — a favorable profile for position sizing, though the 6.82 short ratio and 40% drawdown history argue for disciplined stop placement.
Beta
0.82
0.82x market volatility
Max Drawdown
-40.3%
Largest decline past year
52-Week Range
$20-$34
Price range past year
Annual Return
+3.4%
Cumulative gain past year
| Period | SARO Return | S&P 500 |
|---|---|---|
| 1m | +41.2% | -3.7% |
| 3m | +4.0% | -2.9% |
| 6m | +8.2% | +0.2% |
| 1y | +3.4% | +10.1% |
| ytd | -3.9% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SARO Fundamental Analysis
Revenue is growing but decelerating: Q3 2026 revenue of $1.558 billion rose 3.97% year-over-year from $1.498 billion in Q3 2025, a marked slowdown from the double-digit pace implied by earlier periods, and sequentially revenue declined from $1.600 billion in Q2 2026 and $1.627 billion in Q1 2026. The segment mix shows Commercial Aerospace as the dominant driver at $859.6 million, followed by Business Aviation at $348.5 million and Other at $56.4 million, meaning the commercial aftermarket is the swing factor for the entire growth story. The sequential revenue decline alongside YoY growth suggests a normalization from a strong prior-year base rather than demand collapse, but the deceleration to sub-4% growth is the central fundamental debate and explains why the stock de-rated through 2026 despite positive earnings momentum.
Profitability is solid and improving: Q3 2026 net income was $92.8 million (net margin 5.96%) on gross profit of $261.9 million, a gross margin of 16.82% that expanded from 13.22% in Q1 2026 and 14.90% in Q3 2025. Operating income of $161.1 million (10.34% operating margin) and EBITDA of $214.8 million (13.79% EBITDA margin) both show healthy sequential expansion from Q1's $148.5 million operating income and 9.13% margin, indicating operating leverage is kicking in as cost of revenue growth moderates. EPS of $0.29 in Q3 versus $0.21 a year ago represents roughly 38% earnings growth on just 4% revenue growth — a powerful demonstration of margin expansion, though the 16.8% gross margin is structurally low for industrials and reflects the pass-through nature of MRO parts and labor costs.
Balance sheet and cash flow are adequate but not fortress-like: debt-to-equity stands at 0.918 (total debt to capitalization of 49.2%), the current ratio is a healthy 2.20, and TTM free cash flow is $321.3 million against a $9.42 billion market cap, implying an FCF yield of roughly 3.4%. However, quarterly FCF is highly volatile — Q1 2026 was -$135.1 million due to a $249.0 million working capital drain, Q2 rebounded to +$51.3 million, and Q3 reached +$98.2 million — reflecting the seasonal receivables and inventory swings inherent to MRO. ROE of 10.40% and ROA of 5.67% are modest but improving from near-zero levels in 2024, and the company is actively deleveraging ($144.2 million debt repayment in Q3) while repurchasing stock ($50.0 million in Q3), signaling confidence in internal cash generation despite the working-capital lumpiness.
Quarterly Revenue
$1.6B
2026-09
Revenue YoY Growth
+4.0%
YoY Comparison
Gross Margin
16.8%
Latest Quarter
Free Cash Flow
$321259000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SARO Overvalued?
Because SARO is profitable (Q3 net income of $92.8 million, TTM EPS of $0.0294 on a GAAP basis but $0.29 quarterly), the PE ratio is the appropriate primary metric, and the trailing PE of 34.1x versus a forward PE of 15.5x is the single most important valuation signal here. The enormous gap — forward earnings are expected to more than double relative to trailing — implies the market is pricing in a dramatic EPS step-up, consistent with consensus estimated EPS of $2.535 for the forward period versus the depressed trailing figure; if that estimate is achieved, the stock trades at a reasonable 15.5x, but the trailing 34.1x shows how much execution risk is embedded in the forward number.
On a peer-comparison basis, SARO trades at a PS ratio of 1.55x and EV/Sales of 1.79x, which is inexpensive in absolute terms for an aerospace & defense aftermarket services business, while its EV/EBITDA of 15.55x and PB of 3.53x are more middle-of-the-road. The PEG ratio of 0.016 is distorted by the near-zero trailing EPS base and should be disregarded; more telling is the PCF ratio of 29.7x, which is rich relative to the 1.55x sales multiple and reflects the working-capital-driven volatility in operating cash flow. Without a clean industry-average benchmark in the provided data, the most defensible read is that the 1.55x sales multiple represents a discount to the 4.5x–6.8x PS range the stock commanded through 2025, suggesting the market has materially reset its growth expectations.
Historical context is striking: SARO's PS ratio has collapsed from 8.80x in Q3 2024 and 6.80x in Q2 2025 to 1.55x today, while its PE has compressed from 37.7x in Q2 2025 to 34.1x trailing (and 15.5x forward). The stock is trading near the bottom of its own post-IPO valuation band on nearly every sales-based measure, which either signals a genuine value opportunity if the forward EPS estimate of $2.535 is credible, or reflects fundamental deterioration in the growth outlook that the market is correctly discounting. The forward PE of 15.5x versus the historical 25x–38x range is the crux: if margins hold and growth reaccelerates, the re-rating potential is substantial; if growth stalls below 4%, the multiple may not recover.
PE
34.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~167x
vs. Industry Avg
37.1x
Industry PE ~37.1x*
EV/EBITDA
15.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the deceleration to 3.97% revenue growth and the earnings bridge it must support. The forward PE of 15.5x versus trailing 34.1x requires EPS to roughly double to $2.535, so any shortfall — the low consensus estimate is $2.39891 — would force a sharp re-rating. Gross margin of 16.82% is thin for industrials and reflects pass-through MRO costs, while debt-to-equity of 0.918 and $40.5 million of quarterly interest expense consume a meaningful share of the $161.1 million operating income. Cash flow volatility compounds this: Q1 2026 free cash flow was -$135.1 million on a $249.0 million working capital drain, showing how quickly the 3.4% FCF yield can evaporate.
Market and competitive risks are dominated by valuation compression and the aftermarket cycle. The PS ratio has already collapsed from 8.80x in Q3 2024 to 1.55x, and if growth stays below 4% the multiple may not recover toward its historical 25x–38x PE band. Beta of 0.821 means roughly 18% less market sensitivity than the S&P, so the stock's sharp moves are idiosyncratic and earnings-driven — a favorable sizing profile but one that leaves it exposed to single-print disappointment. The 6.82 short ratio signals meaningful bearish positioning that can amplify drawdowns, and the recent news flow (Textron's Q3 revenue miss and YTD underperformance) hints at softness across aerospace peers that could pressure aftermarket volumes.
Worst-case scenario: commercial aerospace aftermarket volumes stall, Q4 revenue growth slips below 3%, and margin expansion reverses, prompting the forward EPS estimate to be cut toward the low end or below. That would break the 15.5x forward PE thesis and likely retest the October low of $19.76 and the 52-week low of $19.56 — roughly -29% from the current $27.63. A more severe outcome, consistent with the analyst low target of $25.00 (-9.5%) and the historical 40.34% max drawdown, would put shares in the high-teens, implying losses of 30% or more for investors buying at current levels.
FAQ
Ranked by severity: first, the earnings-bridge risk — forward PE of 15.5x versus trailing 34.1x requires EPS to roughly double to $2.535, and the low consensus estimate of $2.39891 leaves little room, so a miss would force a sharp re-rating. Second, growth deceleration — Q3 revenue grew only 3.97% YoY and declined sequentially from $1.600 billion in Q2 and $1.627 billion in Q1, with Commercial Aerospace at $859.6 million as the swing factor for the whole story. Third, margin and leverage risk — gross margin of 16.82% is thin for industrials, debt-to-equity is 0.918, and $40.5 million of quarterly interest expense consumes a meaningful share of $161.1 million operating income. Fourth, cash-flow volatility — Q1 2026 free cash flow was -$135.1 million on a $249.0 million working-capital drain, showing how quickly the 3.4% FCF yield can reverse, compounded by a 6.82 short ratio that can amplify drawdowns.
The scenario framework assigns 50% to a base case of $30–$34, 25% to a bull case of $38–$42.40, and 25% to a bear case of $19.56–$25.00. The base case is most likely: low-to-mid single-digit revenue growth, gross margin at or above 16.5%, and forward EPS of $2.535 broadly achieved, supporting a grind back toward the $33.96 average target and the $34.48 52-week high. The bull case requires revenue growth reaccelerating above 5% with margin durability, driving multiple expansion toward the historical 25x–38x band and a move toward the $42.40 high target (+53%). The bear case assumes growth slips below 3% and margin reverts toward the 13.22% Q1 level, breaking the forward PE thesis and retesting the $19.56 low (-29%). The key assumption across all three is the $2.535 forward EPS estimate holding.
The answer depends heavily on which multiple you anchor to. On trailing earnings the stock looks expensive at 34.1x PE, but that collapses to 15.5x forward on consensus EPS of $2.535 — a level that is undemanding for a recurring-revenue aerospace aftermarket business if the estimate is credible. On sales the stock is cheap in absolute and historical terms: PS of 1.55x and EV/Sales of 1.79x versus 8.80x in Q3 2024 and 6.80x in Q2 2025, while EV/EBITDA of 15.55x and PB of 3.53x are more middle-of-the-road. The market is therefore pricing a durable growth stall and limited multiple recovery, not a return to the 25x–38x PE band the stock once commanded. If margins hold and growth reaccelerates above 5%, the re-rating potential is substantial; if growth stays below 4%, the current discount is deserved rather than an opportunity.
On a risk/reward basis the setup is moderately attractive: at $27.63 the stock sits roughly 20% below its $34.48 52-week high and offers +22.9% upside to the $33.96 average analyst target, with 11 of 14 analysts rating it Buy and zero sell ratings. The valuation is the core support — 15.5x forward PE against a 34.1x trailing multiple and a 1.55x PS ratio near the bottom of its post-IPO range — while Q3 showed 38% EPS growth on gross margin expansion to 16.82%. The biggest downside risk is that revenue growth, already decelerated to 3.97%, stalls further and the $2.535 forward EPS is cut, which could send shares toward the $25.00 analyst low target (-9.5%) or the $19.56 52-week low (-29%). It is a reasonable buy for investors with a 12–24 month horizon who accept earnings-driven volatility (beta 0.821, 40.34% max drawdown) and who size positions around the Q4 print as the key confirmation event; it is less suited to investors needing near-term certainty or income, given a 0% dividend yield.
SARO is better suited to a medium-to-long-term holding than to short-term trading, though its recent behavior cuts both ways. The stock is up 36.44% in the past month against a 4.99% decline in SPY (+41.43 percentage points of relative strength), a mean-reversion surge off the October 14 low of $19.76 that leaves it prone to near-term consolidation — a poor entry for momentum chasers. Longer term, the recurring MRO revenue model, 2.20 current ratio, $321.3 million TTM free cash flow, and active deleveraging ($144.2 million repaid in Q3) support a multi-year thesis, while beta of 0.821 and a 0% dividend yield mean returns must come from earnings growth and multiple re-rating rather than income. A suggested minimum holding period is 12–24 months, long enough to see whether Q4 and subsequent prints confirm the margin inflection and deliver the $2.535 forward EPS; short-term traders should instead watch the $23–25 breakout zone as support and $30–31 as resistance.